Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and methamphetamine in several strains of mice

Progress in Neuropsychopharmacology and Biological Psychiatry

Volumn 12, Issue 2-3, 1988, Pages 345-354

  Sonsalla, Patricia K ^a   Heikkila, Richard E ^b  

^a Department of Neurology University of Medicine ^*  (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Methamphetamine Mouse strain differences MPTP

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMINE OXIDASE (FLAVIN CONTAINING); BRAIN RECEPTOR; METHAMPHETAMINE;

ANIMAL EXPERIMENT; MOUSE; NEUROTOXICITY; NONHUMAN;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMAL; BRAIN; CORPUS STRIATUM; DOPAMINE; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; NEUROTOXINS; PYRIDINES; SPECIES SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023932211     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-5846(88)90054-1     Document Type: Article

References (24)

1. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substanti'a m'gra by N-methyl-4-pheny1-1,2,3,6-tetrahydropyridine
2. Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-pheny1-1,2,3,6-tetrahydropyridine
3. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
4. Reversible neurotoxicity of MPTP in the nigrostriatal dopaminergic system of mice
5. Chronic parkinsonism secondary to intravenous injection of meperidine analogues
6. Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys
7. Effects of amfonelic acid, α-methyltyrosine, Ro 4–1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-pheny1-1,2,3,6-tetrahydropyridine in mice
8. Influence of dopanrine synthesis on methainphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity
9. Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse
10. Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources
11. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyri dine in mice
12. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
13. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain
14. Parkin sonism-inducing neurotoxin, N-methyl-4-pheTiyl-l,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity
15. Mode of action of MPTP on catecholaminergic neurons in the mouse
16. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis
17. Selective nigral toxicity after systemic administration of 1-methyl-4-pheny1-1,2,5,6-tetrahydropyridine (MPTP) in the squirrel monkey
18. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57 black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity
19. Lack of evidence supporting a role for dopamine in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
20. The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice
21. 3-MPTP)-induced neurotoxicity in the mouse
22. Studies on the effect of 1-methyl-4-pheny1-1,2,3,6-tetrahydropyr1d1ne (MPTP) on central catec hoi ami ne neurons in C57 BL/6 mice. Comparison with three other strains of mice
23. Effects of chrome methamphetamine on the nigral-striatal dopamine system in rat brain: tyrosine hydroxylase immunochemistry and quantitative light microscopic studies
24. Long-lasting depletions of striatal dopamlne and loss of dopamine uptake sites following repeated administration of methamphetamlne